IFG Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,651
Closed -$3.92M 663
2025
Q4
$3.92M Buy
3,651
+306
+9% +$293K 0.17% 154
2025
Q3
$2.55M Sell
3,345
-436
-12% -$324K 0.12% 202
2025
Q2
$2.95M Buy
3,781
+54
+1% +$42K 0.15% 174
2025
Q1
$3.08M Buy
3,727
+641
+21% +$533K 0.17% 152
2024
Q4
$2.38M Buy
3,086
+288
+10% +$238K 0.14% 185
2024
Q3
$2.48M Sell
2,798
-182
-6% -$164K 0.16% 169
2024
Q2
$2.7M Sell
2,980
-177
-6% -$142K 0.17% 149
2024
Q1
$2.46M Buy
3,157
+169
+6% +$120K 0.18% 154
2023
Q4
$1.74M Sell
2,988
-114
-4% -$66.5K 0.13% 188
2023
Q3
$1.67M Buy
+3,102
New +$1.6M 0.14% 182
2023
Q2
Sell
-2,590
Closed -$890K 428
2023
Q1
$890K Sell
2,590
-39
-1% -$13.2K 0.08% 224
2022
Q4
$961K Sell
2,629
-577
-18% -$205K 0.1% 216
2022
Q3
$1.04M Buy
3,206
+707
+28% +$224K 0.09% 210
2022
Q2
$810K Buy
2,499
+105
+4% +$31.5K 0.09% 227
2022
Q1
$685K Buy
2,394
+2
+0.1% +$515 0.07% 253
2021
Q4
$660K Buy
2,392
+399
+20% +$101K 0.06% 255
2021
Q3
$460K Sell
1,993
-2
-0.1% -$494 0.05% 310
2021
Q2
$458K Sell
1,995
-81
-4% -$16.3K 0.05% 308
2021
Q1
$387K Buy
2,076
+718
+53% +$140K 0.05% 347
2020
Q4
$229K Buy
+1,358
New +$203K 0.03% 410
2020
Q3
Sell
-1,317
Closed -$216K 415
2020
Q2
$216K Sell
1,317
-181
-12% -$27.8K 0.04% 363
2020
Q1
$207K Buy
+1,498
New +$206K 0.05% 332

Other funds holding LLY

IFG Advisory's LLY Position: Q1 2026 in Review

IFG Advisory sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 3,651 shares — an estimated $3.92M sold.

IFG Advisory first reported a position in LLY in Q1 2020 and held it in 22 quarters. The position peaked at $3.92M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • IFG Advisory reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • IFG Advisory sold 3,651 Eli Lilly shares in Q1 2026, an estimated $3.92M.
  • IFG Advisory first reported a position in Eli Lilly in Q1 2020 and held it in 22 quarters.
  • IFG Advisory's Eli Lilly position peaked at $3.92M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.